Daiwa Securities Group’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-245
Closed -$11K 1342
2025
Q1
$11K Hold
245
﹤0.01% 1092
2024
Q4
$9K Sell
245
-46
-16% -$1.61K ﹤0.01% 1127
2024
Q3
$9K Buy
291
+40
+16% +$1.49K ﹤0.01% 1137
2024
Q2
$9K Hold
251
﹤0.01% 1171
2024
Q1
$12K Hold
251
﹤0.01% 1161
2023
Q4
$9K Hold
251
﹤0.01% 1176
2023
Q3
$6K Hold
251
﹤0.01% 1148
2023
Q2
$7K Hold
251
﹤0.01% 1160
2023
Q1
$6K Hold
251
﹤0.01% 1140
2022
Q4
$7K Buy
251
+67
+36% +$1.65K ﹤0.01% 1136
2022
Q3
$5K Hold
184
﹤0.01% 1164
2022
Q2
$5K Buy
184
+40
+28% +$1.46K ﹤0.01% 1175
2022
Q1
$8K Hold
144
﹤0.01% 1152
2021
Q4
$9K Sell
144
-24
-14% -$1.59K ﹤0.01% 1160
2021
Q3
$11K Buy
168
+76
+83% +$5.86K ﹤0.01% 1131
2021
Q2
$8K Hold
92
﹤0.01% 1054
2021
Q1
$7K Hold
92
﹤0.01% 1062
2020
Q4
$7K Buy
+92
New +$5.92K ﹤0.01% 1037

Other funds holding SWTX

Daiwa Securities Group's SWTX Position: Q2 2025 in Review

Daiwa Securities Group sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 245 shares — an estimated $11K sold.

Daiwa Securities Group first reported a position in SWTX in Q4 2020 and held it in 18 quarters. The position peaked at $12K in Q1 2024. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Daiwa Securities Group reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 245 SpringWorks Therapeutics shares in Q2 2025, an estimated $11K.
  • Daiwa Securities Group first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 18 quarters.
  • Daiwa Securities Group's SpringWorks Therapeutics position peaked at $12K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.